0000000000130491
AUTHOR
Mazzocco K.
The Psychological Risks Associated With the Non-medical Switch From Biologics to Biosimilars
Biological products are therapeutic agents produced using a living system or organism. In many cases, access to these products is limited due to their expensive cost (Chow et al., 2011). A biosimilar is a biological product that is highly similar (not identic) to, and has no clinically meaningful differences from, an existing reference biological product on the market (Desai et al., 2020). “Non-medical” switching is the switching of a patient's medicine for reasons other than the patient's health and safety, like the reduction of costs (Dolinar et al., 2019).
Digital contents as a tool to address research reproducibility crisis in psychology: A case study on sexual attraction under conditions of high arousal
In the field of behavioral sciences, a crisis of the replicability of data took place. Among the reasons of the crisis, there is the difficulty of replicating some classical experimental settings and the lack of reproduced studies. Nowadays, digital contents might provide valuable opportunities to re-create specific environmental situations and manipulations in a safe and cost-saving way. The present study is a preliminary attempt to replicate the relationship between arousal manipulation and sexual attraction as it was assessed in the classical study by Dutton and Aron in 1974. Here, 30 male subjects will be randomly assigned to high or low arousal condition (induced with digital contents)…
A meta-analysis on heart rate variability biofeedback and depressive symptoms
Heart rate variability biofeedback (HRVB) has been used for a number of years to treat depressive symptoms, a common mental health issue, which is often comorbid with other psychopathological and medical conditions. The aim of the present meta-analysis is to test whether and to what extent HRVB is effective in reducing depressive symptoms in adult patients. We conducted a literature search on Pubmed, ProQuest, Ovid PsycInfo, and Embase up to October 2020, and identified 721 studies. Fourteen studies were included in the meta-analysis. Three meta-regressions were also performed to further test whether publication year, the questionnaire used to assess depressive symptoms, or the interval of …